Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke

Abstract Aim The effectiveness of neuroprotective agents is still unclear. Here we analyzed the clinical outcomes of acute ischemic stroke (AIS) patients treated with human urinary kallidinogenase (HUK) or edaravone (Eda) combined with butylphthalide (NBP). Methods From January 2016 to December 2017...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yun Qian, Yi Lyu, Minhai Jiang, Bo Tang, Tian Nie, Shan Lu
Formato: Artigo
Lenguaje:Inglês
Publicado: Wiley 2019-12-01
Colección:Brain and Behavior
Materias:
acute ischemic stroke
butylphthalide
edaravone
human urinary kallidinogenase
Acceso en línea:https://doi.org/10.1002/brb3.1438
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares